Please enter both an email address and a password.

Account login

Need to reset your password?  Enter the email address which you used to register on this site (or your membership/contact number) and we'll email you a link to reset it. You must complete the process within 2hrs of receiving the link.

We've sent you an email

An email has been sent to Simply follow the link provided in the email to reset your password. If you can't find the email please check your junk or spam folder and add to your address book.

Updates from MHRA

14 Feb 2017

New online Yellow Card app to report medicines and devices on the go

An online Yellow Card Scheme is now available to report all adverse incidents related to medical devices, including performance concerns for diagnostics, defective medicines and counterfeit products. The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding physicians and surgeons that prompt reporting makes medicines and devices safer and is part of a healthcare professional’s responsibility to improving patient safety.

Only a suspicion that a medicine or vaccine might have caused a suspected adverse drug reaction (ADR) or that a medical device is performing outside its expected characteristics is needed to complete a Yellow Card. The card can be completed online or through the Yellow Card app. The app can be downloaded for free from iTunes Yellow Card or PlayStore Yellow Card and it allows physicians and surgeons to create a ‘watch list’ of medications to receive official alerts on or view the number of Yellow Cards received by the MHRA for medicines of interest.

Breast and Cosmetic Implant Registry (BCIR)

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding all providers of breast implant surgery about the importance of participating in the Breast and Cosmetic Implant Registry (BCIR). The registry, launched in October 2016 in response to the Keogh Review of the regulation of cosmetic interventions, captures details of all breast implant procedures completed in England by the NHS and private providers.

The BCIR will help monitoring the safety and performance of breast implants by supporting the identification of possible trends and complications relating to specific implants and it will allow patients to be traced in the event that implants ever need to be recalled and removed. The MHRA expects providers to educate patients on the importance and benefits of being included in the registry and seek their written consent to add their details.

Share this page: